U.S. FDA approves genetically modified salmon for human consumption

Arirang News 2015-11-20

Views 10

Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
U.S. approves genetically modified salmon as safe to eat
play
00:45

U.S. approves genetically modified salmon as safe to eat
Argentina becomes world's first country to approve genetically modified wheat
play
00:37

Argentina becomes world's first country to approve genetically modified wheat
FDA gives preliminary approval for trial to deploy genetically engineered mosquitoes to fight Zika
play
00:44

FDA gives preliminary approval for trial to deploy genetically engineered mosquitoes to fight Zika
U.S. FDA approves Moderna's COVID-19 vaccine
play
00:39

U.S. FDA approves Moderna's COVID-19 vaccine
FDA approves first at-home COVID-19 test kit which doesn't require prescription
play
00:34

FDA approves first at-home COVID-19 test kit which doesn't require prescription
U.S. FDA approves Moderna vaccine for emergency use
play
00:37

U.S. FDA approves Moderna vaccine for emergency use
FDA approves Celltrion’s biosimilar drug Remsima for sales in U.S.
play
02:28

FDA approves Celltrion’s biosimilar drug Remsima for sales in U.S.
FDA approves Celltrion’s biosimilar drug Remsima for sales in U.S.
play
01:56

FDA approves Celltrion’s biosimilar drug Remsima for sales in U.S.
U.S. FDA approves first antigen test kit for COVID-19
play
00:49

U.S. FDA approves first antigen test kit for COVID-19
FDA approves Sivextro to treat skin infections
play
00:40

FDA approves Sivextro to treat skin infections
U.S. FDA approves emergency authorization of convalescent plasma to treat COVID-19 patients
play
00:49

U.S. FDA approves emergency authorization of convalescent plasma to treat COVID-19 patients
U.S. FDA approves emergency authorization of convalescent plasma to treat COVID-19 patients
play
01:34

U.S. FDA approves emergency authorization of convalescent plasma to treat COVID-19 patients